Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3 Meeting Abstract
| Authors: | Migden, M. R.; Schmults, C.; Khushanlani, N.; Guminski, A.; Chang, A. L.; Lewis, K.; Ansstas, G.; Bowyer, S. E.; Hughes, B. G. M.; Schadendorf, D.; Modi, B.; Dunn, L.; Flatz, L.; Hauschild, A.; Yoo, S. Y.; Booth, J.; Seebach, F.; Lowy, I.; Fury, M. G.; Rischin, D. |
| Abstract Title: | Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3 |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S918 |
| End Page: | S919 |
| Language: | English |
| ACCESSION: | WOS:000866211601085 |
| DOI: | 10.1016/j.annonc.2022.07.940 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 814P -- Source: Wos |
